Becerra Sidesteps Question About Use Of March-In To Lower Drug Prices

HHS Secretary-nominee Xavier Becerra sidestepped a question about whether he thinks the government can seize patents on government-funded drugs to help spur generic competition, coming months after he called on the federal government to use so-called march-in rights to help develop lower-cost generic versions of Gilead’s COVID-19 therapy remdesivir. During Becerra’s Senate Finance Committee confirmation hearing Wednesday (Feb. 24), GOP Sen. Patrick Toomey (PA) pointed to a letter the California attorney general wrote in August alongside 34 other state attorneys...